e-learning
resources
2022
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension
Marcos V.F. Garcia, Rogerio Souza, Pedro Caruso
Source:
ERJ Open Res, 8 (1) 00006-2022; 10.1183/23120541.00006-2022
Journal Issue:
January
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Marcos V.F. Garcia, Rogerio Souza, Pedro Caruso. External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension. ERJ Open Res, 8 (1) 00006-2022; 10.1183/23120541.00006-2022
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Reply: External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension
Source: ERJ Open Res, 8 (1) 00066-2022; 10.1183/23120541.00066-2022
Year: 2022
emPHasis-10 score predicts mortality in patients with pulmonary hypertension
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018
Predicting mortality in acute cardiogenic pulmonary edema: Validation of the BACH-score in a prospective cohort
Source: Annual Congress 2010 - Intensive care unit outcome
Year: 2010
Predicting short-term mortality in patients with pulmonary embolism: A simple model
Source: Annual Congress 2010 - Pulmonary embolism
Year: 2010
Evaluation of sequential organ failure assessment (SOFA) based models for predicting mortality in ICU patients
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
Biomarkers model for prediction of hospitalisation duration and pulmonary embolism outcome
Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients
Year: 2021
Utility of D-Dimer for mortality prediction in patients at risk for pulmonary hypertension
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Non-invasive mortality predictors in pediatric pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure
Source: Eur Respir J, 58 (3) 2100466; 10.1183/13993003.00466-2021
Year: 2021
Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy
Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017
Year: 2018
Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017
Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
Source: Eur Respir J, 52 (5) 1800248; 10.1183/13993003.00248-2018
Year: 2018
Response to non-invasive ventilation as a predictor for mortality in patients with acute respiratory failure due to acute exacerbation of COPD
Source: International Congress 2017 – Noninvasive ventilation for acute respiratory failure
Year: 2017
In-hospital mortality of acute pulmonary thromboembolism: comparison between patients with objective diagnosis and non-confirmed suspicion
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008
Design and assessment of an automated prediction model for 30-day re-hospitalization after a COPD exacerbation using genetic algorithms
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019
Risk assessment in scleroderma patients with newly diagnosed pulmonary arterial hypertension: application of the ESC/ERS risk prediction model
Source: Eur Respir J, 52 (4) 1800497; 10.1183/13993003.00497-2018
Year: 2018
Validation of a prognostic score for pulmonary embolism short-term mortality
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Index of myocardial injury CIIS and mortality of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD management
Year: 2011
Modification of the simplified PESI score to identify low risk patients with acute symptomatic pulmonary embolism
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Myocardial infarction, heart failure and mortality in patients with COPD in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept